Zhejiang ShiLai Bioengineering Co., Ltd. provides premium Osimertinib intermediate, a critical building block for third-generation EGFR tyrosine kinase inhibitor development. Manufactured under strict quality control standards, our Osimertinib intermediate ensures high purity, batch-to-batch consistency, and reliable performance for R&D, drug development, and API synthesis applications.
Copyright©2025 Oclorus™ - All Rights Reserved.
Powered by Oclorus™